White House taps Inglesby as COVID testing coordinator

By

By Reuters Staff

WASHINGTON (Reuters) - The White House has tapped Dr. Tom Inglesby, the former director of Johns Hopkins Center for Health Security, to lead the government's COVID-19 testing initiative, press secretary Jen Psaki said on Tuesday.

The appointment, confirmed by Psaki in a Twitter post, comes as the federal government seeks to ramp up testing amid the fast-spreading Omicron variant.

"Dr. Inglesby is one of the world's leading infectious disease experts and is internationally recognized in the fields of public health preparedness, pandemic and emerging infectious disease, and prevention of and response to biological threats," a White House official told Reuters.

The United States reported 1.35 million new coronavirus infections on Monday https://www.reuters.com/business/healthcare-pharmaceuticals/us-reports-least-11-mln-covid-cases-day-shattering-global-record-2022-01-11, shattering the global record for daily cases in any one country. Omicron is now estimated to account for 98.3% of total new cases circulating in the country, the Centers for Disease Control and Prevention (CDC) says.

Critics have accused President Joe Biden of not focusing enough on testing in the fight to control surging Omicron cases and hospitalizations, amid growing reports of acute shortages of test kits around the country.

The White House and top health officials have defended the response, including announcing this month that 500 million rapid tests would be available free to all Americans in January.

Related Articles

UPDATE 1-U.S. suicide hotline 988 is set to go live, but many states may not be ready

(Adds Lifeline calls in Washington and Wyoming, paragraph 10) By Barbara Goldberg NEW YORK (Reuters) - In just six months, 988 goes live as the shortcut to call or text the U.S. suicide hotline at a Read More »

COLUMN-A quiet experiment is testing broader privatization of U.S. Medicare

(The opinions expressed here are those of the author, a columnist for Reuters.) By Mark Miller (Reuters) - Millions of retirees have opted out of traditional Medicare over the past two decades, Read More »

EMA lists rare spinal condition as side effect of AstraZeneca's COVID-19 shot

By Reuters Staff (Reuters) - A safety panel of the European drug regulator on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca's COVID-19 Read More »